Oregon Senator Delays Bill Granting PDAB UPL Authority Amid Uncertainty
Oregon Senator Deb Patterson, Chair of the Senate Health Care Committee, has decided not to introduce a bill this session…
Browsing: Drug Pricing: Policy Activity
Youngkin Vetoes PDAB Bill in Virginia for Second Year
For the second consecutive year, Governor Glenn Youngkin has vetoed legislation aimed at establishing a Prescription Drug Affordability Board (PDAB).…
Aimed Alliance Asks Kansas to Consider Alternative to PDAB Legislation
Aimed Alliance submitted a letter to the Kansas Legislature, urging the Committee on Financial Institutions and Insurance to evaluate the…
Aimed Alliance Supports Creation of Rare Disease Council in Washington
Aimed Alliance provided a letter of support for the passage of Washington Senate Bill 5064, which would establish an advisory…
Aimed Alliance Comments on Maryland PDAB Draft Rules
Aimed Alliance provided feedback on Maryland’s Prescription Drug Affordability Board’s draft regulations, COMAR 14.01.0 and COMAR 14.01.05, which amend and…
Aimed Alliance Urges Virginia to Reconsider PDAB Bill
On January 24, 2025, Aimed Alliance submitted a comment to the Virginia House Appropriations – Health and Human Resources Subcommittee,…
Survey Finds 30% of Independent Pharmacies Will Not Stock Certain IRA-Negotiated Drugs
New data released by the National Community Pharmacists Association (NCPA) finds that roughly 30 percent of independent pharmacies have chosen…
Aimed Alliance Advocates for Clarifications to WA Obesity Treatment Access Legislation
In February 2025, Aimed Alliance submitted a comment on Washington Senate Bill 5353, which would require health carriers to provide…
Aimed Alliance Urges Patient-Focused Amendments to MD PDAB Bill
Aimed Alliance provided comments on Maryland’s SB0357/HB0424, legislation that would enable the Maryland Prescription Drug Affordability Board (PDAB) to establish…
Aimed Alliance Comments Urging Revisions to Maryland’s New PDAB Rules
On November 8, 2024, Aimed Alliance submitted feedback to the Maryland Prescription Drug Affordability Board regarding its updated rules for…